These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21269330)

  • 1. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
    Yoon SO; Yu E; Cho YM; Suh C; Kim KM; Han DJ; Lee SG; Huh J
    Clin Transplant; 2012; 26(1):67-73. PubMed ID: 21269330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
    J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience.
    Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ
    Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
    Ghobrial IM; Habermann TM; Maurer MJ; Geyer SM; Ristow KM; Larson TS; Walker RC; Ansell SM; Macon WR; Gores GG; Stegall MD; McGregor CG
    J Clin Oncol; 2005 Oct; 23(30):7574-82. PubMed ID: 16186599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
    Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients.
    Schober T; Framke T; Kreipe H; Schulz TF; Großhennig A; Hussein K; Baumann U; Pape L; Schubert S; Wingen AM; Jack T; Koch A; Klein C; Maecker-Kolhoff B
    Transplantation; 2013 Jan; 95(1):240-6. PubMed ID: 23222898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
    Wudhikarn K; Holman CJ; Linan M; Blaes AH; Dunitz JM; Hertz ME; Peterson BA
    Clin Transplant; 2011; 25(5):705-13. PubMed ID: 21077949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades.
    Michonneau D; Suarez F; Lambert J; Adam J; Brousse N; Canioni D; Anglicheau D; Martinez F; Snanoudj R; Legendre C; Hermine O; Mamzer-Bruneel MF
    Nephrol Dial Transplant; 2013 Feb; 28(2):471-8. PubMed ID: 23129824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-early onset post-transplantation lymphoproliferative disease.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1144-52. PubMed ID: 24231475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
    Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
    J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
    Khedmat H; Taheri S
    Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-pathological analysis of 6 cases of post-transplant lymphoproliferative disorders].
    Wang ZM; Zheng SS; Ding W; Wang LJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):514-8. PubMed ID: 18078125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
    Orjuela MA; Alobeid B; Liu X; Siebert AL; Kott ER; Addonizio LJ; Morris E; Garvin JH; Lobritto SJ; Cairo MS
    Br J Haematol; 2011 Mar; 152(6):733-42. PubMed ID: 21275950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
    Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.